Fairness Opinion
Duff & Phelps Provides a Fairness Opinion to the Board of Directors of NN, Inc. on the Sale of Its Life Sciences Division to American Securities LLC
has entered into an agreement to sell its Life Sciences division to
In August 2020, NN, Inc. (NASDAQ: NNBR), a diversified industrial company, announced a definitive agreement under which NN, Inc.'s Life Sciences division will be purchased by affiliates of American Securities LLC for the purpose of being combined with its portfolio company, MW Industries, a provider of highly engineered springs, specialty fasteners, bellows and other precision components.
The transaction is expected to be completed in the fourth quarter of 2020, subject to customary closing conditions. Following the close of the transaction, the Life Sciences division will combine with MW Industries.
Duff & Phelps served as a financial advisor to the board of directors of NN, Inc.and provided an independent fairness opinion in connection with the transaction.
About NN, Inc.
NN, Inc., a diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has 48 facilities in North America, Europe, South America, and China. Simpson Thacher & Bartlett LLP served as legal counsel to NN, Inc.
Fairness and Solvency Opinions
Duff & Phelps Opinions is a global leader in Fairness Opinions and Special Committee Advisory, ranking #1 for total number of U.S. and global fairness opinions over the past 10 years, according to Refinitiv cumulative data from 2013-2022.
Transaction Advisory Services
Kroll’s Transaction Advisory Services platform offers corporate and financial investors with deep accounting and technical expertise, commercial knowledge, industry insight and seamless analytical services throughout the deal continuum. Duff & Phelps acquired Kroll in 2018 and unified under the Kroll brand in 2020.
Kroll’s Healthcare Investment Banking Practice Advised LSL Healthcare on Its Recapitalization by 5th Century Partners
Kroll's Healthcare Investment Banking Team Advised TRI–AD on Its Sale to Navia Benefit Solutions
Kroll's Transaction Advisory Team Rendered Financial Due Diligence to Denali Growth Partners on Its Investment in Boston Veterinary Clinic
Kroll’s Healthcare Investment Banking Practice Advised LSL Healthcare on Its Recapitalization by 5th Century Partners
Kroll's Healthcare Investment Banking Team Advised TRI–AD on Its Sale to Navia Benefit Solutions
Kroll's Transaction Advisory Team Rendered Financial Due Diligence to Denali Growth Partners on Its Investment in Boston Veterinary Clinic